Table 3.
Regression coefficient | OR | 95%CI | P-value | |
---|---|---|---|---|
Ipsilateral vascular pathology (model excluding presenting symptoms) | ||||
Sex, male | 0.457 | 1.579 | 1.049–2.377 | 0.029 |
Duration of Symptoms | −0.368 | 0.692 | 0.542–0.884 | 0.003 |
Arterial Hypertension | 0.541 | 1.718 | 0.951–3.104 | 0.073 |
Coronary heart disease | 0.650 | 1.916 | 1.184–3.101 | 0.008 |
Intercept | −1.723 | 0.179 | < 0.001 | |
Ipsilateral vascular pathology (model including presenting symptoms) | ||||
Sex, male | 0.433 | 1.542 | 1.023–2.326 | 0.039 |
Duration of Symptoms | −0.402 | 0.669 | 0.522–0.857 | 0.001 |
Arterial Hypertension | 0.561 | 1.753 | 0.968–3.173 | 0.064 |
Coronary heart disease | 0.662 | 1.939 | 1.196–3.145 | 0.007 |
Vertigo | 0.462 | 1.587 | 1.001–2.516 | 0.049 |
Intercept | −1.751 | 0.174 | < 0.001 | |
Need for invasive treatment (model excluding presenting symptoms) | ||||
Duration of symptoms | −0.570 | 0.565 | 0.378–0.846 | 0.006 |
Arterial Hypertension | 0.960 | 2.612 | 0.895–7.621 | 0.079 |
Hyperlipidaemia | 1.737 | 5.681 | 0.766–42.117 | 0.089 |
Atrial fibrillation | −1.293 | 0.274 | 0.082–0.917 | 0.036 |
Intercept | −4.023 | 0.018 | 0.001 | |
Need for invasive treatment (model including presenting symptoms) | ||||
Duration of symptoms | −0.600 | 0.549 | 0.363–0.892 | 0.004 |
Arterial Hypertension | 0.971 | 2.639 | 0.896–7.774 | 0.078 |
Hyperlipidaemia | 1.761 | 5.821 | 0.781–43.363 | 0.086 |
Atrial fibrillation | −1.323 | 0.266 | 0.079–0.901 | 0.033 |
Dysarthria | −1.135 | 0.321 | 0.096–1.078 | 0.066 |
Hemiparesis | 0.978 | 2.659 | 1.325–5.337 | 0.006 |
Intercept | −4.243 | 0.014 | < 0.001 |
OR Odds ratio, CI Confidence interval